CN101254325A - Use method of hydrochloric acid ritodrine injection and special transfusion pump - Google Patents
Use method of hydrochloric acid ritodrine injection and special transfusion pump Download PDFInfo
- Publication number
- CN101254325A CN101254325A CNA200810027280XA CN200810027280A CN101254325A CN 101254325 A CN101254325 A CN 101254325A CN A200810027280X A CNA200810027280X A CN A200810027280XA CN 200810027280 A CN200810027280 A CN 200810027280A CN 101254325 A CN101254325 A CN 101254325A
- Authority
- CN
- China
- Prior art keywords
- injection
- infusion pump
- infusion
- ritodrine
- hydrochloric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002347 injection Methods 0.000 title claims abstract description 31
- 239000007924 injection Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims description 24
- 229960001634 ritodrine Drugs 0.000 title claims description 14
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 title claims 4
- 238000001802 infusion Methods 0.000 claims abstract description 51
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- IOVGROKTTNBUGK-SJKOYZFVSA-N (1S,2R)-ritodrine Chemical compound N([C@H](C)[C@@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJKOYZFVSA-N 0.000 abstract description 20
- 229960000720 ritodrine hydrochloride Drugs 0.000 abstract description 10
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 230000001276 controlling effect Effects 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 230000008774 maternal effect Effects 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 description 3
- 230000035935 pregnancy Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 1
- 101710152983 Beta-2 adrenergic receptor Proteins 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005381 potential energy Methods 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Abstract
The invention discloses a using method of a ritodrine hydrochloride injection and a special infusion pump thereof. The invention firstly applies the infusion pump in the injection of the ritodrine hydrochloride injection. The infusion pump includes an infusion pump main body structure, and the interior of the infusion pump main body structure is provided with an automatic control device for controlling the injection flow rate and the injection time. The medical staff just needs to carry out the simple operation according to a pre-set process table on the automatic control device, and then the injection of the ritodrine hydrochloride can be accurately and safely realized. When the pre-set process table is not applicable to a particular patient, the infusion flow rate and the time can be regulated, thus allowing the infusion pump to be operated automatically according to the procedure after the adjustment. The infusion pump overcomes the difficulty of the shortage of the hospital medical staff, eliminates the differences of the infusion sets with the different specifications during the infusion process, significantly improves the safety of the clinical application of the ritodrine hydrochloride injection and reduces the maternal and the fetal personal dangerousness.
Description
Technical field
The present invention relates to a kind of injecting method and equipment thereof of hydrochloric acid ritodrine injection.
Background technology
Ritodrine hydrochloride (Ritodrine, YUTOPAR, Ritodrine Hydrochloride) is a beta 2 adrenoreceptor agonists, and the beta 2 receptor in can exciting uterine smooth muscle suppresses the contraction of uterine smooth muscle, reduces the activity in uterus and prolongs trimester of pregnancy.Be used to prevent gestation later premature labor of 20 week clinically.The dosage form of using that it is common is tablet and injection.
Infusion pump is a kind of device of safe, accurate control transfusion.The infusion mode that past people is familiar with is to utilize the potential energy of liquid to be used as power, and is difficult to control steadily in the long term transfusion speed and amount of infusion.Infusion pump has been applied to the medical care field clinically, is used for substituting manual injection's operation, but the infusion pump of prior art be can not fluid drive, non-programmable infusion pump, they all are not suitable for the injection of ritodrine hydrochloride.Reason is to guaranteeing the safety of puerpera and fetus, use hydrochloric acid ritodrine injection to need a strict control liquor strength and a speed clinically, but in the middle of the practice, because a variety of causes makes that manually the above-mentioned injecting method of control is difficult to by strictly, as one man carries out, as the specification difference of transfusion device, medical personnel's level difference, time control inaccuracy, it is wayward more more slowly to drip speed, and medical personnel are inadequate etc., and the result has increased the life danger of puerpera and fetus.Up to now, still find no the people infusion pump is applied to the injection of hydrochloric acid ritodrine injection, more be not exclusively used in the infusion pump of ritodrine hydrochloride.
Summary of the invention
The objective of the invention is to overcome the defective that exists in the prior art, a kind of using method of hydrochloric acid ritodrine injection accurate, safe and reliable, easy to use is provided.
Another object of the present invention provides the special transfusion pump of realizing that above-mentioned using method adopted.
For realizing purpose of the present invention, the present invention is applied to infusion pump the injection of hydrochloric acid ritodrine injection for the first time.This infusion pump comprises the infusion pump agent structure, is provided with control injection flow velocity and the automaton of inject time in the infusion pump agent structure.
Described automaton realizes that by software control hardware components is a prior art, and software section comprises the automatic infusion module, interface and display module are set.The transfusion of automatic infusion module controls is carried out according to special time and corresponding flow velocity.Interface is set to be used for regulating infusion flow rate and time according to patient.Display module is used for flow velocity, time and amount of infusion of transfusion or the like come out by screen display.
The control procedure preferred version of automatic infusion module is as shown in the table:
| Segment number | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| Flow velocity (ml/h) | 15 | 30 | 45 | 60 | 75 | 90 | 105 |
| Time (min) | 10 | 10 | 10 | 10 | 10 | 10 | To finishing |
Compared with prior art, the present invention has following beneficial effect: the present invention introduces the syringe pump with automatic control function in the ritodrine hydrochloride injection, thereby realizes dripping the strictness control of speed and time.The medical worker only needs to carry out simple operations according to predefined process table on the automaton, can be accurately and realize the injection of ritodrine hydrochloride safely.When especial patient occurring, predefined process table can not where applicable, can regulate infusion flow rate and time, allows infusion pump according to the Automatic Program operation of setting.This has overcome the part medical care medical personnel of department difficulty in short supply, has eliminated the diversity of different size transfusion device in infusion process, makes the safety of clinical practice hydrochloric acid ritodrine injection significantly improve, and has reduced the personal dangerousness of puerpera and fetus.
Description of drawings
Fig. 1 is the structural representation of infusion pump of the present invention.
The specific embodiment
The following specific embodiment describes the present invention in detail, but the present invention is not imposed any restrictions:
The injection concentration of preparation hydrochloric acid ritodrine injection is 0.2mg/ml.
As shown in Figure 1, infusion pump of the present invention comprises the infusion pump agent structure, is provided with control injection flow velocity and the automaton of inject time in the infusion pump agent structure.Automaton is realized its control function by software control, and hardware components is existing equipment, and software includes the automatic infusion module, interface and display module are set.Shown in the following process table of the automatic control process of automatic infusion module:
| Segment number | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| Flow velocity (ml/b) | 15 | 30 | 45 | 60 | 75 | 90 | 105 |
| Time (min) | 10 | 10 | 10 | 10 | 10 | 10 | To finishing |
Interface is set is connected, be used for regulating infusion flow rate and time according to patient with the automatic infusion module.Interface is set heightens or to turn down flow velocity, can suspend or keep transfusion, can begin or finish.When the inapplicable process table of patient's physical qualification, can regulate flow velocity and time by interface is set.The variation of flow velocity can be from 1～100 droplet/minute, and the time variation can be from 1～20 minute, and injection concentration changes can be from 0.01～0.5mg/ml.Display module is connected with the automatic infusion module, be used for will transfusion flow velocity, time, preset value and cumulative amount or the like come out by screen display.
Claims (7)
1, a kind of infusion pump that is exclusively used in hydrochloric acid ritodrine injection comprises the infusion pump agent structure, it is characterized in that being provided with in the infusion pump agent structure control injection flow velocity and the automaton of inject time.
2, infusion pump as claimed in claim 1 is characterized in that, described automaton comprises the automatic infusion module.
3, infusion pump as claimed in claim 2 is characterized in that, the control procedure of described automatic infusion module is: inject according to special time and corresponding flow velocity.
4, infusion pump as claimed in claim 3 is characterized in that, the control procedure of described automatic infusion module is as shown in the table.
5, infusion pump as claimed in claim 2 is characterized in that, described automaton comprises interface is set.
6, infusion pump as claimed in claim 2 is characterized in that, described automaton comprises display module.
7, a kind of using method of hydrochloric acid ritodrine injection is characterized in that adopting the described infusion pump of claim 1 that hydrochloric acid ritodrine injection is injected into human body.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810027280XA CN101254325B (en) | 2008-04-08 | 2008-04-08 | Use method of hydrochloric acid ritodrine injection and special transfusion pump |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200810027280XA CN101254325B (en) | 2008-04-08 | 2008-04-08 | Use method of hydrochloric acid ritodrine injection and special transfusion pump |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101254325A true CN101254325A (en) | 2008-09-03 |
| CN101254325B CN101254325B (en) | 2010-09-15 |
Family
ID=39889640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200810027280XA Active CN101254325B (en) | 2008-04-08 | 2008-04-08 | Use method of hydrochloric acid ritodrine injection and special transfusion pump |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101254325B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108704190A (en) * | 2009-12-04 | 2018-10-26 | 史密斯医疗Asd公司 | It is conveyed for the advanced step therapy of portable infusion pump and its system |
-
2008
- 2008-04-08 CN CN200810027280XA patent/CN101254325B/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108704190A (en) * | 2009-12-04 | 2018-10-26 | 史密斯医疗Asd公司 | It is conveyed for the advanced step therapy of portable infusion pump and its system |
| US11090432B2 (en) | 2009-12-04 | 2021-08-17 | Smiths Medical Asd, Inc. | Advanced step therapy delivery for an ambulatory infusion pump and system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101254325B (en) | 2010-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE19983113B3 (en) | Pressure / Force Computer-controlled drug delivery system | |
| Calkins et al. | The microbead occlusion model of ocular hypertension in mice | |
| CN108969838B (en) | Automatic medicine changing monitoring control system for infusion | |
| CN105833383B (en) | A kind of automatic infusion robot | |
| CN106473924B (en) | A kind of automation molten dispensing system molten dispensing unit machine and molten dosage | |
| CN106725815A (en) | A kind of bone cement remote control injection device | |
| CN107412903A (en) | A kind of injection device of double syringe | |
| CN210963388U (en) | Interventional therapy needle for internal medicine | |
| CN101254325B (en) | Use method of hydrochloric acid ritodrine injection and special transfusion pump | |
| DE102006039675B4 (en) | Method and device for filling an adding device of a therapy device | |
| KR102058412B1 (en) | A computer-implemented method for controlling dispensing of a biologically active agent, computer system and software thereof | |
| CN201175496Y (en) | Transfusion pump special for hydrochloric acid ritodrine injection | |
| CN207804701U (en) | A kind of injection device of double syringe | |
| CN204995911U (en) | Full automatic -mixing injects pump | |
| CN215082280U (en) | Novel medicine mixer for blending intravenous medicines in medical department | |
| CN202262991U (en) | Body blood sugar automatic test and control device | |
| CN204582270U (en) | A kind of prostate dilation operation automaton | |
| CN202263246U (en) | Disposable transfusion dispensing device | |
| CN205181921U (en) | Remote control syringe pump | |
| CN210542638U (en) | Blood back transfusion device | |
| CN208852144U (en) | Venous detaining needle | |
| CN212327113U (en) | Injection positioning device for endocrine clinic | |
| CN201200690Y (en) | Novel needle for skin test | |
| CN208756702U (en) | A kind of multi-functional injecting propeller | |
| CN203493993U (en) | Brain glioma postoperative embedded automatic radiation and chemotherapy pump |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: XIANQIANG PHARMACEUTICAL CO., LTD., GUANGDONG Free format text: FORMER OWNER: ZHANG ZHISHENG Effective date: 20120210 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510405 GUANGZHOU, GUANGDONG PROVINCE TO: 510990 GUANGZHOU, GUANGDONG PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120210 Address after: 510990 Industrial Road, Conghua Economic Development Zone, Guangzhou, Guangdong, Guangdong Patentee after: Xianqiang Pharmaceutical Co., Ltd., Guangdong Address before: 510405, Jinmao Tower, No. 17, Airport Road, Baiyun District, Guangdong, Guangzhou 703 Patentee before: Zhang Zhisheng |
|
| C56 | Change in the name or address of the patentee |
Owner name: GUANGDONG XIANQIANG PHARMACEUTICAL CO., LTD. Free format text: FORMER NAME: XIANQIANG PHARMACEUTICAL CO., LTD., GUANGDONG |
|
| CP03 | Change of name, title or address |
Address after: 510990 No. 6, Industrial Avenue, Conghua Economic Development Zone, Guangdong, Guangzhou Patentee after: Guangdong Xianqiang Pharmaceutical Co., Ltd. Address before: 510990 Industrial Road, Conghua Economic Development Zone, Guangzhou, Guangdong, Guangdong Patentee before: Xianqiang Pharmaceutical Co., Ltd., Guangdong |
|
| C56 | Change in the name or address of the patentee |
Owner name: XIANQIANG PHARMACEUTICAL CO., LTD., GUANGDONG Free format text: FORMER NAME: GUANGDONG XIANQIANG PHARMACEUTICAL CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Address after: 510990 No. 6, Industrial Avenue, Conghua Economic Development Zone, Guangdong, Guangzhou Patentee after: Xianqiang Pharmaceutical Co., Ltd., Guangdong Address before: 510990 No. 6, Industrial Avenue, Conghua Economic Development Zone, Guangdong, Guangzhou Patentee before: Guangdong Xianqiang Pharmaceutical Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20201118 Address after: No.6, Gongye Avenue, Conghua Economic Development Zone, Guangzhou City, Guangdong Province Patentee after: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. Patentee after: Guangdong Zhongsheng Pharmaceutical Co.,Ltd. Patentee after: GUANGDONG HUANAN PHARMACY Ltd. Address before: 510990 No. 6, Industrial Avenue, Conghua Economic Development Zone, Guangdong, Guangzhou Patentee before: GUANGDONG XIANQIANG PHARMACEUTICAL Co.,Ltd. |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Huang Caifeng Document name: Notice of conformity |